BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18772454)

  • 41. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo.
    Snapper SB; Meelu P; Nguyen D; Stockton BM; Bozza P; Alt FW; Rosen FS; von Andrian UH; Klein C
    J Leukoc Biol; 2005 Jun; 77(6):993-8. PubMed ID: 15774550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-7 is required for the development of the intrinsic function of marginal zone B cells and the marginal zone microenvironment.
    Willems L; Li S; Rutgeerts O; Lenaerts C; Waer M; Billiau AD
    J Immunol; 2011 Oct; 187(7):3587-94. PubMed ID: 21873520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression.
    Yamaguchi K; Ariga T; Yamada M; Nelson DL; Kobayashi R; Kobayashi C; Noguchi Y; Ito Y; Katamura K; Nagatoshi Y; Kondo S; Katoh H; Sakiyama Y
    Blood; 2002 Aug; 100(4):1208-14. PubMed ID: 12149199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha.
    Gallego MD; de la Fuente MA; Anton IM; Snapper S; Fuhlbrigge R; Geha RS
    Int Immunol; 2006 Feb; 18(2):221-32. PubMed ID: 16141245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrabodies against the EVH1 domain of Wiskott-Aldrich syndrome protein inhibit T cell receptor signaling in transgenic mice T cells.
    Sato M; Iwaya R; Ogihara K; Sawahata R; Kitani H; Chiba J; Kurosawa Y; Sekikawa K
    FEBS J; 2005 Dec; 272(23):6131-44. PubMed ID: 16302976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient antigen presentation of soluble, but not particulate, antigen in the absence of Wiskott-Aldrich syndrome protein.
    Westerberg L; Wallin RP; Greicius G; Ljunggren HG; Severinson E
    Immunology; 2003 Jul; 109(3):384-91. PubMed ID: 12807484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice.
    Soh SY; Faveeuw C; Thiam CH; Khoo LH; Yeo KP; Lim SY; Lim HY; Ng JX; Angeli V
    J Immunol; 2016 Nov; 197(10):3894-3904. PubMed ID: 27798147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity.
    Becker-Herman S; Meyer-Bahlburg A; Schwartz MA; Jackson SW; Hudkins KL; Liu C; Sather BD; Khim S; Liggitt D; Song W; Silverman GJ; Alpers CE; Rawlings DJ
    J Exp Med; 2011 Sep; 208(10):2033-42. PubMed ID: 21875954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. gp49B-mediated negative regulation of antibody production by memory and marginal zone B cells.
    Fukao S; Haniuda K; Nojima T; Takai T; Kitamura D
    J Immunol; 2014 Jul; 193(2):635-44. PubMed ID: 24935931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone.
    Muppidi JR; Arnon TI; Bronevetsky Y; Veerapen N; Tanaka M; Besra GS; Cyster JG
    J Exp Med; 2011 Sep; 208(10):1941-8. PubMed ID: 21875957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B cell hyperresponsiveness and expansion of mature follicular B cells but not of marginal zone B cells in NFATc2/c3 double-deficient mice.
    Samanta DN; Palmetshofer A; Marinkovic D; Wirth T; Serfling E; Nitschke L
    J Immunol; 2005 Apr; 174(8):4797-802. PubMed ID: 15814705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. WASP-mediated regulation of anti-inflammatory macrophages is IL-10 dependent and is critical for intestinal homeostasis.
    Biswas A; Shouval DS; Griffith A; Goettel JA; Field M; Kang YH; Konnikova L; Janssen E; Redhu NS; Thrasher AJ; Chatila T; Kuchroo VK; Geha RS; Notarangelo LD; Pai SY; Horwitz BH; Snapper SB
    Nat Commun; 2018 May; 9(1):1779. PubMed ID: 29725003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome.
    Lutskiy MI; Park JY; Remold SK; Remold-O'Donnell E
    PLoS One; 2008; 3(10):e3444. PubMed ID: 18941616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells.
    Baptista MA; Keszei M; Oliveira M; Sunahara KK; Andersson J; Dahlberg CI; Worth AJ; Liedén A; Kuo IC; Wallin RP; Snapper SB; Eidsmo L; Scheynius A; Karlsson MC; Bouma G; Burns SO; Forsell MN; Thrasher AJ; Nylén S; Westerberg LS
    Nat Commun; 2016 Jul; 7():12175. PubMed ID: 27425374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4+ T-cell motility by regulating adhesion to intercellular adhesion molecule-1.
    Lafouresse F; Cotta-de-Almeida V; Malet-Engra G; Galy A; Valitutti S; Dupré L
    Immunology; 2012 Oct; 137(2):183-96. PubMed ID: 22804504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Src kinase Hck association with the WASp and mDia1 cytoskeletal regulators promotes chemoattractant-induced Hck membrane targeting and activation in neutrophils.
    Shi Y; Dong B; Miliotis H; Liu J; Alberts AS; Zhang J; Siminovitch KA
    Biochem Cell Biol; 2009 Feb; 87(1):207-16. PubMed ID: 19234535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wiskott-Aldrich syndrome protein--dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes.
    Matalon O; Reicher B; Barda-Saad M
    Immunol Rev; 2013 Nov; 256(1):10-29. PubMed ID: 24117810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
    Snapper SB; Rosen FS
    Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wiskott-Aldrich syndrome protein may be critical for CD8
    Li S; Huang J; Zhang YL; Zhu Y; An YF; Du J; Zhang ZL; Xia Y; Liu L; Wang L; Luo XH
    Cell Immunol; 2019 Apr; 338():43-50. PubMed ID: 30981413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.